Trastuzumabemtansine versus treatment of physician ’ s choice for pretreated HER2-positive advanced breast cancer(TH3RESA):a randomised,open-label,phase 3 trial .ASCO,American Society of Clinical Oncology . Systemic Therapy for Patients With Advanced Huma ......